Docteurs SPRIMONT & WANET, Cardiologie et Radiothérapie
0635.689.203 · rovalta.com · 28/09/2026
Docteurs SPRIMONT & WANET, Cardiologie et Radiothérapie
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODocteurs SPRIMONT & WANET, Cardiologie et Radiothérapie is a Private limited company incorporated in 2015. Its registered office is in La Bruyère.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0635.689.203
- Incorporation
- 21/08/2015
- Legal form
- Private limited company
- Registered office
- Rue de la Gloriette, Emines 2A
5080 La Bruyère · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 10 filingsTrend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 406,1 k € | +15.1% | 352,8 k € | +9.1% | 323,3 k € | +43.3% | 225,6 k € | +36.9% | 164,8 k € |
| EBITDA | 400,6 k € | +14.9% | 348,6 k € | +9.2% | 319,2 k € | +43.9% | 221,8 k € | +38.4% | 160,3 k € |
| Operating result | 347,7 k € | +17.0% | 297,1 k € | +11.0% | 267,7 k € | +56.4% | 171,1 k € | +53.6% | 111,4 k € |
| Net result | 260 k € | +18.2% | 220 k € | +12.4% | 195,7 k € | +57.2% | 124,5 k € | +49.2% | 83,4 k € |
| Balance sheet | |||||||||
| Equity | 216,1 k € | +38.4% | 156,1 k € | +14.7% | 136,1 k € | -3.1% | 140,4 k € | -15.4% | 165,9 k € |
| Total assets | 1,1 M € | +12.3% | 950,4 k € | +18.6% | 801,2 k € | -11.9% | 909,6 k € | +5.5% | 862 k € |
| Cash | 316,6 k € | +70.6% | 185,6 k € | +258% | 51,8 k € | -61.4% | 134,2 k € | +4.8% | 128 k € |
| Debts | 851,5 k € | +7.2% | 794,2 k € | +19.4% | 665,1 k € | -13.5% | 769,1 k € | +10.5% | 696,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
MARIE WANET | DirectorManagerended | |
PIERRE SPRIMONT | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/08/2026 | 28/08/2025 | 29/08/2024 | 25/08/2023 | 30/09/2022 | 30/08/2021 |
| General meeting | 19/06/2026 | 20/06/2025 | 21/06/2024 | 16/06/2023 | 31/08/2022 | 18/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 19/06/2026 | 28/08/2026 | French | |
| Micro model | 31/12/2024 | 20/06/2025 | 28/08/2025 | French | |
| Micro model | 31/12/2023 | 21/06/2024 | 29/08/2024 | French | |
| Micro model | 31/12/2022 | 16/06/2023 | 25/08/2023 | French | |
| Micro model | 31/12/2021 | 31/08/2022 | 30/09/2022 | French | |
| Micro model | 31/12/2020 | 18/06/2021 | 30/08/2021 | French | |
| Micro model | 31/12/2019 | 19/06/2020 | 13/08/2020 | French | |
| Micro model | 31/12/2018 | 21/06/2019 | 29/08/2019 | French | |
| Micro model | 31/12/2017 | 15/06/2018 | 17/07/2018 | French | |
| Abridged model | 31/12/2016 | 16/06/2017 | 31/08/2017 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
MARIE WANET | DirectorManagerended | |
PIERRE SPRIMONT | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de la Gloriette, Emines 2A, 5080 RhisnesCurrent | CBE | |
| Rue de la Gloriette 2 bte A, 5080 Rhisnes | accounts 2021 → 2025 | Accounts 2025 · 2026-00485150 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Docteurs SPRIMONT & WANET, Cardiologie et RadiothérapieCurrent | CBE | |
| DOCTEURS SPRIMONT ET WANET | accounts 2021 → 2025 | Accounts 2025 · 2026-00485150 |
Events
- 2025Annual accounts 2025260 k €↑
- 2024Annual accounts 2024220 k €↑
- 2023Annual accounts 2023195,7 k €↑
- 2022Annual accounts 2022124,5 k €↑
- 2021Annual accounts 202183,4 k €↑
- 2020Annual accounts 20204,5 k €↓
- 2019Annual accounts 201986 k €↑
- 2018Annual accounts 201880 k €↑
- 2017Annual accounts 201760,8 k €↓
- 2016Annual accounts 2016132,6 k €
- 21/08/2015IncorporationPrivate limited company